Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 89 of 200 · By data quality, then INN

  1. nivolumab

    OPDIVO Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FF01

  2. nogapendekin alfa inbakicept-pmln

    ANKTIVA

    INTRAVESICAL FDA: approved

  3. nonoxynol-9

    TODAY

    VAGINAL FDA: approved

  4. norfloxacin

    APO-NORFLOXACIN Lacuna Pharma Pty Ltd

    OPHTHALMIC FDA: approved · TGA: approved

  5. norgestimate

    TRI-LO-LINYAH

    ORAL FDA: approved

  6. norgestrel

    OPILL

    ORAL FDA: approved

  7. novobiocin sodium

    ALBAMYCIN

    ORAL FDA: approved

  8. nusinersen sodium

    SPINRAZA INITIAL APPROVAL

    INTRATHECAL FDA: approved · PMDA: approved

  9. obeticholic acid

    OCALIVA Amdipharm Mercury (Australia) Pty Limited

    ORAL FDA: approved · EMA: unknown · TGA: approved

    A05AA04

  10. obiltoxaximab

    NYXTHRACIS (PREVIOUSLY OBILTOXAXIMAB SFL)

    INJECTION FDA: approved · EMA: withdrawn

    J06BB22

  11. obinutuzumab

    GAZYVA Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01FA03

  12. ocrelizumab

    OCREVUS Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L04AG08

  13. ocrelizumab and hyaluronidase-ocsq

    OCREVUS ZUNOVO

    INJECTION FDA: approved

  14. ocriplasmin

    JETREA

    INTRAVITREAL FDA: approved · EMA: withdrawn

    S01XA22

  15. odevixibat

    BYLVAY Ipsen

    ORAL FDA: approved · EMA: approved · TGA: approved

    A05AX

  16. ofatumumab

    KESIMPTA Novartis Pharmaceuticals

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AA52

  17. olanzapine pamoate

    ZYPREXA RELPREVV

    INTRAMUSCULAR FDA: approved

  18. olaparib

    LYNPARZA AstraZeneca

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01XK01

  19. olaratumab

    LARTRUVO

    INJECTION FDA: approved · EMA: unknown

    L01XC27

  20. oliceridine

    OLINVYK

    INTRAVENOUS FDA: approved

  21. olipudase alfa-rpcp

    XENPOZYME

    INJECTION FDA: approved

  22. olive oil

    CLINOLIPID 20%

    INTRAVENOUS FDA: approved

  23. olodaterol hydrochloride

    STRIVERDI RESPIMAT

    INHALATION FDA: approved

  24. olsalazine sodium

    DIPENTUM

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.